Mien‐Chie Hung
- Oncology top 0.01%
- HER2/EGFR in Cancer Research 123
- Cancer-related Molecular Pathways 80
- Cancer Research top 0.01%
- Molecular Biology top 0.01%
- RNA Interference and Gene Delivery 48
- Epigenetics and DNA Methylation 46
- Ubiquitin and proteasome pathways 44
- RNA modifications and cancer 43
- Immunology top 0.1%
- Cell Biology top 0.05%
-
- Monoclonal and Polyclonal Antibodies Research 87
-
- Virus-based gene therapy research 56
- Co-authors
- Weiya XiaDihua YuBinhua P. ZhouGabriel N. HortobágyiRobert A. WeinbergHirohito YamaguchiCornelia I. BargmannYongkun Wei
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Mien‐Chie Hung
736 papers receiving 66.3k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Oncology 28.0k
- Cancer Research 13.8k
- Molecular Biology 43.4k
- Immunology 8.4k
- Cell Biology 5.1k
Countries citing papers authored by Mien‐Chie Hung
This map shows the geographic impact of Mien‐Chie Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mien‐Chie Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mien‐Chie Hung more than expected).
Fields of papers citing papers by Mien‐Chie Hung
This network shows the impact of papers produced by Mien‐Chie Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mien‐Chie Hung. The network helps show where Mien‐Chie Hung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mien‐Chie Hung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 14 | |
| 6 | 2020 | 101 | |
| 7 | 2020 | 133 | |
| 8 | 2017 | 21 | |
| 9 | 2016 | 146 | |
| 10 | 2016 | 49 | |
| 11 | 2014 | 12 | |
| 12 | 2014 | 211 | |
| 13 | 2013 | 110 | |
| 14 | 2012 | 21 | |
| 15 | 2011 | 21 | |
| 16 | 2010 | 16 | |
| 17 | 2010 | 60 | |
| 18 | 2009 | 98 | |
| 19 | 2009 | 30 | |
| 20 | 2007 | 155 |
About Mien‐Chie Hung
Mien‐Chie Hung is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 745 papers that have together received 67.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (123 papers), Monoclonal and Polyclonal Antibodies Research (87 papers), Cancer-related Molecular Pathways (80 papers), Virus-based gene therapy research (56 papers), RNA Interference and Gene Delivery (48 papers), Epigenetics and DNA Methylation (46 papers), Ubiquitin and proteasome pathways (44 papers) and RNA modifications and cancer (43 papers). The work is most often cited by research in Oncology (28.0k citations), Cancer Research (13.8k citations) and Molecular Biology (43.4k citations). Mien‐Chie Hung has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Weiya Xia, Dihua Yu, Binhua P. Zhou, Gabriel N. Hortobágyi, Robert A. Weinberg, Hirohito Yamaguchi, Cornelia I. Bargmann, Yongkun Wei, Jung-Mao Hsu and Yong Liao. Their work appears in journals such as Cancer Research, Oncogene, Journal of Biological Chemistry, Cancer Cell and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.